论文部分内容阅读
为了探讨活血化瘀方药防治肝纤维化的机理，以猪血清诱发大鼠免疫性肝纤维化为模型，以肝组织ＣＣＯ的活性、血清ＧＰＴ的含量等为观察内容，实验分正常、模型、预防和治疗４组。结果证明：活血化瘀方药有较显著的抗肝纤维化的作用，预防效果尤为明显。
In order to investigate the mechanism of the prevention and treatment of liver fibrosis by the method of activating blood circulation and removing blood stasis, the model of immune hepatic fibrosis induced by pig serum was used. The activity of CCO in serum and the content of serum GPT were observed. The experiment was divided into normal, model, and prevention. And treatment 4 groups. The results showed that: Activating Blood Circulation to Remove Blood Stasis Formula has a significant anti-hepatic fibrosis effect, and the prevention effect is particularly obvious.